SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Exelixis, Inc. (EXEL)
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
930 66 0 EXEL
Emcee:  kinkblot Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
505What? Only $140m upfront??? You people are easily impressed. :)kenhott-5/28/2009
504Not much wrong with that.nigel bates-5/28/2009
503Yes, and it's not even April 1st.Ian@SI-5/28/2009
502:-)scaram(o)uche-5/28/2009
501Conf call in about 6 1/2 hours... Exelixis and Sanofi-aventis Sign Global LicenIan@SI-5/28/2009
500<b>Exelixis drug shows promise in brain cancer-study</b> reuters.coidos-5/15/2009
499Tuck sorry.. I duplicated this!mlkr-5/8/2009
498More cash to EXEL by germans this time! 2. Exelixis, Boehringer enter $354M automlkr-5/8/2009
497cc: Exelixis, Inc. Q1 2009 Earnings Call Transcript SeekingAlpha May 7, 2009 5:mopgcw-5/8/2009
496Same pathway as NVS’ FTY720.DewDiligence_on_SI-5/7/2009
495>>Exelixis and Boehringer Ingelheim Enter into Collaboration for Developmetuck-5/7/2009
494Seven Abstracts Featuring Exelixis Compounds to Be Presented at 2009 ASCO Annualmopgcw-4/25/2009
493Management and the Board should be ashamed. The recent proxy continues the ongomopgcw54/15/2009
492i agree that was an interesting spin to it...cheeky even.mopgcw-3/6/2009
491Exelixis Announces Fourth Quarter and Full Year 2008 Financial Results Business mopgcw-3/6/2009
490<i>>…our collaboration with GSK ended as scheduled in October last yearDewDiligence_on_SI-3/5/2009
489cc: Exelixis Inc Q4 2008 Earnings Call Transcript March 04, 2009 Executives mopgcw-3/5/2009
488Entry into a Material Definitive Agreement, Other Events Item 1.01. Entry into Icebrg-12/22/2008
487What does paulsonwagoner call it?tom pope-12/12/2008
486<i>News flash: EXEL has accumulated about $1B of losses during its relativIan@SI-12/12/2008
485News flash: EXEL has accumulated about $1B of losses during its relatively shortDewDiligence_on_SI112/12/2008
484They owe GSK a $100m but unless they get a partnership with like $100m upfront okenhott-12/12/2008
483>> Good to see that cash can still be shaken loose for the right deal. <scaram(o)uche-12/12/2008
482Nice upfront. Good to see that cash can still be shaken loose for the right deanigel bates-12/12/2008
481They did have Analyst Day scheduled for today and Scangos had been making noise rkrw-12/12/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):